Human papillomaviruses are one of the principal infectious agents known to cause cancers in humans;it is estimated that approximately 5% of cancers worldwide are attributable to HPV infection. While it is well established that HPV is a necessary cause of cervical cancer, world experts agree that for HPV16, the most carcinogenic of the HPV genotypes, data show a causal role in cancers outside the cervix, including the vulva, vagina, penis, and anus, and some head and neck tumors in the oropharynx. Other cancers hypothesized to be related to HPV infection, but for which a causal association has yet to be shown, include cancers of the oral cavity, larynx, conjunctiva, and, for cutaneous HPV types, skin. To that end, considerable research within the IIB focuses on the role of HPV infection in cancer at extra-cervical sites. We have many on-going studies whose aims are to:1) evaluate the natural history of HPV infections at non-cervical sites 2) determine the prevalence and biologic activity of HPV infection in tumors from these sites3) assess the prospective association between HPV infection and risk of extra-cervical prevalent, incident, and recurrent cancers 4) evaluate the efficacy of the HPV16/18 prophylactic vaccine against extra-cervical infections

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Investigator-Initiated Intramural Research Projects (ZIA)
Project #
1ZIACP010209-05
Application #
8938270
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Cancer Epidemiology and Genetics
Department
Type
DUNS #
City
State
Country
Zip Code
Kreimer, Aimée R; Johansson, Mattias; Yanik, Elizabeth L et al. (2017) Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer. J Natl Cancer Inst 109:
Beachler, Daniel C; Waterboer, Tim; Pierce Campbell, Christine M et al. (2016) HPV16 E6 seropositivity among cancer-free men with oral, anal or genital HPV16 infection. Papillomavirus Res 2:141-144
Kreimer, Aimée R; Struyf, Frank; Del Rosario-Raymundo, Maria Rowena et al. (2015) Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials. Lancet Oncol 16:775-86
Gonzalez, Paula; Hildesheim, Allan; Herrero, Rolando et al. (2015) Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa Rica. Vaccine 33:2141-51
Pierce Campbell, Christine M; Kreimer, Aimée R; Lin, Hui-Yi et al. (2015) Long-term persistence of oral human papillomavirus type 16: the HPV Infection in Men (HIM) study. Cancer Prev Res (Phila) 8:190-6
Shiels, Meredith S; Kreimer, Aimée R; Coghill, Anna E et al. (2015) Anal Cancer Incidence in the United States, 1977-2011: Distinct Patterns by Histology and Behavior. Cancer Epidemiol Biomarkers Prev 24:1548-56
Giuliano, Anna R; Kreimer, Aimée R; de Sanjose, Silvia (2015) The beginning of the end: vaccine prevention of HPV-driven cancers. J Natl Cancer Inst 107:djv128
Lang Kuhs, Krystle A; Anantharaman, Devasena; Waterboer, Tim et al. (2015) Human Papillomavirus 16 E6 Antibodies in Individuals without Diagnosed Cancer: A Pooled Analysis. Cancer Epidemiol Biomarkers Prev 24:683-9
Kreimer, Aimée R; Brennan, Paul; Lang Kuhs, Krystle A et al. (2015) Human papillomavirus antibodies and future risk of anogenital cancer: a nested case-control study in the European prospective investigation into cancer and nutrition study. J Clin Oncol 33:877-84
Kreimer, Aimée R; Johansson, Mattias; Hildesheim, Allan et al. (2014) Reply to P.E. Castle. J Clin Oncol 32:361-2

Showing the most recent 10 out of 16 publications